Cargando…
Necdin modulates leukemia-initiating cell quiescence and chemotherapy response
Acute myeloid leukemia (AML) is a devastating illness which carries a very poor prognosis, with most patients living less than 18 months. Leukemia relapse may occur because current therapies eliminate proliferating leukemia cells but fail to eradicate quiescent leukemia-initiating cells (LICs) that...
Autores principales: | Yao, Chonghua, Kobayashi, Michihiro, Chen, Sisi, Nabinger, Sarah C., Gao, Rui, Liu, Stephen Z., Asai, Takashi, Liu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675657/ https://www.ncbi.nlm.nih.gov/pubmed/29152105 http://dx.doi.org/10.18632/oncotarget.20999 |
Ejemplares similares
-
Necdin, a p53 target gene, in stem cells
por: Asai, Takashi, et al.
Publicado: (2013) -
Functional Consequences of Necdin Nucleocytoplasmic Localization
por: Lavi-Itzkovitz, Anat, et al.
Publicado: (2012) -
Sequence variation of necdin gene in Bovidae
por: Peters, Sunday O., et al.
Publicado: (2018) -
The alpha subunit of Go modulates cell proliferation and differentiation through interactions with Necdin
por: Ju, Hyunhee, et al.
Publicado: (2014) -
Necdin Controls Proliferation of White Adipocyte Progenitor Cells
por: Fujiwara, Kazushiro, et al.
Publicado: (2012)